BridgeBio Pharma, Inc.
US ˙ NasdaqGS ˙ US10806X1028

SecurityBBIO / BridgeBio Pharma, Inc.
InstitutionSimplex Trading, Llc
Latest Disclosed Ownership41,434 shares
Latest Disclosed Value $ 3,076,888
Simplex Trading, Llc ownership in BBIO / BridgeBio Pharma, Inc.

On May 14, 2026 - Simplex Trading, Llc filed a 13F-HR form disclosing ownership of 41,434 shares of BridgeBio Pharma, Inc. (US:BBIO) valued at $3,076,889 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 18,412 shares of BridgeBio Pharma, Inc.. This represents a change in shares of 125.04% during the quarter. The current value of the position is $2,713,098 USD.

Simplex Trading, Llc has a history of taking positions in derivatives of the underlying security (BBIO) in the form of stock options. The firm currently holds call options representing 36,100 of underlying shares valued at $2,680,786 USD and put options representing 74,000 of underlying shares valued at $5,495,240 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

BBIO / BridgeBio Pharma, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F BRIDGEBIO PHARMA COM 10806X102 41,434 23,022 125.04 3,077 118.47 0.0021
2026-02-11 2025-12-31 13F BRIDGEBIO PHARMA COM 10806X102 18,412 18,412 1,408 0.0008
2025-05-12 2025-03-31 13F BRIDGEBIO PHARMA COM 10806X102 0 -15,256 -100.00 0 0.0000
2025-02-11 2024-12-31 13F BRIDGEBIO PHARMA COM 10806X102 15,256 -17,243 -53.06 0 0.0002
2024-11-08 2024-09-30 13F BRIDGEBIO PHARMA COM 10806X102 32,499 -48,733 -59.99 1 -100.00 0.0005
2024-07-25 2024-06-30 13F BRIDGEBIO PHARMA COM 10806X102 81,232 81,232 2 0.0013
2023-11-01 2023-09-30 13F BRIDGEBIO PHARMA COM 10806X102 0 -900 -100.00 0 0.0000
2023-08-04 2023-06-30 13F BRIDGEBIO PHARMA COM 10806X102 900 -128,227 -99.30 0 -100.00 0.0000
2023-04-27 2023-03-31 13F BRIDGEBIO PHARMA COM 10806X102 129,127 129,127 2 0.0019
2023-02-02 2022-12-31 13F BRIDGEBIO PHARMA COM 10806X102 0 -705 -100.00 0 -100.00
2022-11-04 2022-09-30 13F BRIDGEBIO PHARMA COM 10806X102 705 -42,530 -98.37 7 -98.21 0.0000
2022-08-03 2022-06-30 13F BRIDGEBIO PHARMA COM 10806X102 43,235 43,235 392 0.0004
2022-05-02 2022-03-31 13F BRIDGEBIO PHARMA COM 10806X102 0 -47,810 -100.00 0 -100.00
2022-02-23 2021-12-31 13F/A-1 BRIDGEBIO PHARMA COM 10806X102 47,810 47,810 797 0.0008
2021-02-02 2020-12-31 13F BRIDGEBIO PHARMA COM 10806X102 0 -3,463 -100.00 0 -100.00
2020-10-14 2020-09-30 13F BRIDGEBIO PHARMA COM 10806X102 3,463 3,463 129 0.0002
2020-07-13 2020-06-30 13F BRIDGEBIO PHARMA COM 10806X102 0 -4,570 -100.00 0 -100.00
2020-04-29 2020-03-31 13F BRIDGEBIO PHARMA COM 10806X102 4,570 4,570 132 0.0002
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-14 2026-03-31 13F BRIDGEBIO PHARMA CALL Call 36,100 -71.28 2,681 -72.12 n/a n/a n/a
2026-02-11 2025-12-31 13F BRIDGEBIO PHARMA CALL Call 125,700 -38.53 9,615 96,040.00 n/a n/a n/a
2025-11-12 2025-09-30 13F BRIDGEBIO PHARMA CALL Call 204,500 -29.73 11 -16.67 n/a n/a n/a
2025-08-05 2025-06-30 13F BRIDGEBIO PHARMA CALL Call 291,000 -5.00 13 20.00 n/a n/a n/a
2025-05-12 2025-03-31 13F BRIDGEBIO PHARMA CALL Call 306,300 -18.93 11 0.00 n/a n/a n/a
2025-02-11 2024-12-31 13F BRIDGEBIO PHARMA CALL Call 377,800 56.83 10 66.67 n/a n/a n/a
2024-11-08 2024-09-30 13F BRIDGEBIO PHARMA CALL Call 240,900 -0.62 6 0.00 n/a n/a n/a
2024-07-25 2024-06-30 13F BRIDGEBIO PHARMA CALL Call 242,400 17.10 6 0.00 n/a n/a n/a
2024-04-25 2024-03-31 13F BRIDGEBIO PHARMA CALL Call 207,000 39.11 6 0.00 n/a n/a n/a
2024-02-02 2023-12-31 13F BRIDGEBIO PHARMA CALL Call 148,800 -51.15 6 -25.00 n/a n/a n/a
2023-11-01 2023-09-30 13F BRIDGEBIO PHARMA CALL Call 304,600 -10.62 8 60.00 n/a n/a n/a
2023-08-04 2023-06-30 13F BRIDGEBIO PHARMA CALL Call 340,800 51.20 6 66.67 n/a n/a n/a
2023-04-27 2023-03-31 13F BRIDGEBIO PHARMA CALL Call 225,400 184.60 4 n/a n/a n/a
2023-02-02 2022-12-31 13F BRIDGEBIO PHARMA CALL Call 79,200 130.23 1 -100.00 n/a n/a n/a
2022-11-04 2022-09-30 13F BRIDGEBIO PHARMA CALL Call 34,400 -61.65 341 -58.11 n/a n/a n/a
2022-08-03 2022-06-30 13F BRIDGEBIO PHARMA CALL Call 89,700 -28.35 814 -35.91 n/a n/a n/a
2022-05-02 2022-03-31 13F BRIDGEBIO PHARMA CALL Call 125,200 -39.11 1,270 -62.96 n/a n/a n/a
2022-02-23 2021-12-31 13F/A BRIDGEBIO PHARMA CALL Call 205,600 102,700.00 3,429 28,475.00 n/a n/a n/a
2022-02-04 2021-12-31 13F BRIDGEBIO PHARMA CALL Call 100 6 n/a n/a n/a
2021-10-28 2021-09-30 13F BRIDGEBIO PHARMA CALL Call 200 100.00 12 100.00 n/a n/a n/a
2021-08-12 2021-06-30 13F BRIDGEBIO PHARMA CALL Call 100 900.00 6 -90.16 n/a n/a n/a
2021-04-26 2021-03-31 13F BRIDGEBIO PHARMA CALL Call 10 -93.15 61 -94.12 n/a n/a n/a
2021-02-02 2020-12-31 13F BRIDGEBIO PHARMA CALL Call 146 1,360.00 1,038 1,601.64 n/a n/a n/a
2020-10-14 2020-09-30 13F BRIDGEBIO PHARMA CALL Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-07-13 2020-06-30 13F BRIDGEBIO PHARMA CALL Call 480 1,163.16 1,565 1,322.73 n/a n/a n/a
2020-04-29 2020-03-31 13F BRIDGEBIO PHARMA CALL Call 38 110 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-14 2026-03-31 13F BRIDGEBIO PHARMA PUT Put 74,000 245.79 5,495 235.88 n/a n/a n/a
2026-02-11 2025-12-31 13F BRIDGEBIO PHARMA PUT Put 21,400 -46.23 1,637 81,700.00 n/a n/a n/a
2025-11-12 2025-09-30 13F BRIDGEBIO PHARMA PUT Put 39,800 -58.41 2 -50.00 n/a n/a n/a
2025-08-05 2025-06-30 13F BRIDGEBIO PHARMA PUT Put 95,700 34.98 4 100.00 n/a n/a n/a
2025-05-12 2025-03-31 13F BRIDGEBIO PHARMA PUT Put 70,900 -53.20 2 -50.00 n/a n/a n/a
2025-02-11 2024-12-31 13F BRIDGEBIO PHARMA PUT Put 151,500 9.47 4 33.33 n/a n/a n/a
2024-11-08 2024-09-30 13F BRIDGEBIO PHARMA PUT Put 138,400 -51.03 4 -57.14 n/a n/a n/a
2024-07-25 2024-06-30 13F BRIDGEBIO PHARMA PUT Put 282,600 36.26 7 16.67 n/a n/a n/a
2024-04-25 2024-03-31 13F BRIDGEBIO PHARMA PUT Put 207,400 73.56 6 50.00 n/a n/a n/a
2024-02-02 2023-12-31 13F BRIDGEBIO PHARMA PUT Put 119,500 -57.67 5 -42.86 n/a n/a n/a
2023-11-01 2023-09-30 13F BRIDGEBIO PHARMA PUT Put 282,300 30.88 7 133.33 n/a n/a n/a
2023-08-04 2023-06-30 13F BRIDGEBIO PHARMA PUT Put 215,700 -66.74 4 -70.00 n/a n/a n/a
2023-04-27 2023-03-31 13F BRIDGEBIO PHARMA PUT Put 648,600 7,907.41 11 n/a n/a n/a
2023-02-02 2022-12-31 13F BRIDGEBIO PHARMA PUT Put 8,100 -67.34 0 -100.00 n/a n/a n/a
2022-11-04 2022-09-30 13F BRIDGEBIO PHARMA PUT Put 24,800 -3.88 246 5.13 n/a n/a n/a
2022-08-03 2022-06-30 13F BRIDGEBIO PHARMA PUT Put 25,800 145.71 234 120.75 n/a n/a n/a
2022-05-02 2022-03-31 13F BRIDGEBIO PHARMA PUT Put 10,500 -88.14 106 -92.82 n/a n/a n/a
2022-02-23 2021-12-31 13F/A BRIDGEBIO PHARMA PUT Put 88,500 5,105.88 1,476 1,266.67 n/a n/a n/a
2022-02-04 2021-12-31 13F BRIDGEBIO PHARMA PUT Put 1,700 108 n/a n/a n/a
2021-10-28 2021-09-30 13F BRIDGEBIO PHARMA PUT Put 1,700 0.00 108 4.85 n/a n/a n/a
2021-08-12 2021-06-30 13F BRIDGEBIO PHARMA PUT Put 1,700 3,169.23 103 -67.81 n/a n/a n/a
2021-04-26 2021-03-31 13F BRIDGEBIO PHARMA PUT Put 52 940.00 320 814.29 n/a n/a n/a
2021-02-02 2020-12-31 13F BRIDGEBIO PHARMA PUT Put 5 -89.36 35 -80.11 n/a n/a n/a
2020-10-14 2020-09-30 13F BRIDGEBIO PHARMA PUT Put 47 -9.62 176 4.14 n/a n/a n/a
2020-07-13 2020-06-30 13F BRIDGEBIO PHARMA PUT Put 52 -44.68 169 -37.87 n/a n/a n/a
2020-04-29 2020-03-31 13F BRIDGEBIO PHARMA PUT Put 94 272 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.